About KYORIN Pharmaceutical
KYORIN Pharmaceutical is a publicly listed company based in Chiyoda (Japan) founded in 1923. Pharmaceuticals are manufactured and sold by KYORIN Pharmaceutical. The company has 2,000 employees. KYORIN Pharmaceutical has completed 1 acquisition, including ActivX. Its website kyorin-pharm.co.jp draws about 51 thousand monthly visits. KYORIN Pharmaceutical offers products and services including New Pharmaceuticals and Generic Drugs. Its focus areas include Traditional Pharmaceuticals. Its legal entity is Kyorin Pharmaceutical Co., Ltd.
Company details
KYORIN Pharmaceutical was established in 1923 and is headquartered in Chiyoda City, Japan. Operations focus on the pharmaceutical sector, where research, development, manufacturing, and sales of medications are conducted. Products are distributed primarily in Japan, addressing various therapeutic areas including respiratory and infectious diseases. The company maintains a presence in the healthcare industry through regulatory compliance and partnerships.
- Headquarters Chiyoda, Japan
- Employees 2,000
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website kyorin-pharm.co.jp
- Legal Name Kyorin Pharmaceutical Co.,Ltd.
- Annual Revenue$791.61 M (USD)-2.94as on Mar 31, 2026
- Net Profit$21.63 M (USD)-62.05as on Mar 31, 2026
- EBITDA$51.54 M (USD)-52.06as on Mar 31, 2026
- Employee Count2,000
- Investments & Acquisitions
Products & Services of KYORIN Pharmaceutical
KYORIN Pharmaceutical offers a comprehensive portfolio of products and services, including New Pharmaceuticals and Generic Drugs.
New pharmaceuticals are developed and marketed for various treatments, focusing on areas like infectious diseases
Generic drugs are produced and distributed to support healthcare needs after initial patents expire
IPO & Listings of KYORIN Pharmaceutical
KYORIN Pharmaceutical is a publicly listed company on the TSE with ticker symbol 4569 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date10 Mar 2006
- Listed onTSE: 45690
- Listed entityKYORIN Pharmaceutical Co.,Ltd.
- Exchange sectorHealth technology
- ISINJP3247090008
- Share price1,074.00 JPY (+0.28% on the day) · 2026-10-14
- Market capitalisation56,377,075,733.00 JPY
- Price to earnings28.4
- EPS (diluted, trailing year)37.81 JPY
- Dividend yield4.39%
- Volume (last session)136,500
Financials of KYORIN Pharmaceutical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 126.26B JPY | 3.45B JPY | 8.22B JPY |
| 2024 | 130.09B JPY | 9.09B JPY | 17.15B JPY |
| 2023 | 119.53B JPY | 5.47B JPY | 10.52B JPY |
| 2022 | 113.27B JPY | 4.72B JPY | 8.96B JPY |
| 2021 | 105.53B JPY | 3.93B JPY | 8.72B JPY |
Detailed financial statements for KYORIN Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by KYORIN Pharmaceutical
KYORIN Pharmaceutical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ActivX.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of kinase and protease targeted drugs for oncology, hematology, and metabolic diseases | activx.com | San Diego, United States | 2000 | Dec 2004 | $21M |
Complete acquisition details for KYORIN Pharmaceutical
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of KYORIN Pharmaceutical
3 dated milestones of KYORIN Pharmaceutical across 83 years, from founding to its latest funding, stage changes and deals.
- Founded KYORIN Pharmaceutical is founded.
- Acquisition Acquires ActivX.
- IPO Lists on the stock exchange (IPO).
Web traffic of KYORIN Pharmaceutical
The website of KYORIN Pharmaceutical (kyorin-pharm.co.jp) receives about 51.3K visits a month and ranks #474,764 among all websites worldwide, #457 in Biotechnology and Pharmaceuticals.
- Monthly visits51.3K
▼ 20.8% vs previous month
- Unique visitors38.1K
per month
- Global rank#474,764
among all websites
- Category rank#457
Health · Biotechnology and Pharmaceuticals
- Bounce rate43%
- Pages per visit3.0
- Average visit2 min 49 sec
- DevicesDesktop 40% · Mobile 60%
Websites whose visitors overlap most with KYORIN Pharmaceutical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
kyorin-medicalbridge.jp | kyorin-medicalbridge.jp | 100% | #1,953,556 | – | |
| kyorin-gr.co.jp | 90% | 1.3K | #12,855,357 | View details | |
kyorin-rmd.co.jp | kyorin-rmd.co.jp | 87% | #1,867,335 | – | |
dgs-on-line.com | dgs-on-line.com | 82% | #841,588 | – | |
otsuka.co.jp | otsuka.co.jp | 80% | #76,610 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for KYORIN Pharmaceutical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kyorin Pharmaceutical
Complete news archive for KYORIN Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KYORIN Pharmaceutical
KYORIN Pharmaceutical was founded in 1923.
KYORIN Pharmaceutical is headquartered in Chiyoda, Japan. It is registered at Chiyoda, Tokyo, Japan.
KYORIN Pharmaceutical has 2,000 employees.
Annual revenue of KYORIN Pharmaceutical is $791.61M as on Mar 31, 2026.
KYORIN Pharmaceutical was established in 1923 and is headquartered in Chiyoda City, Japan. Operations focus on the pharmaceutical sector, where research, development, manufacturing, and sales of medications are conducted. Products are distributed primarily in Japan, addressing various therapeutic areas including respiratory and infectious diseases. The company maintains a presence in the healthcare industry through regulatory compliance and partnerships.
KYORIN Pharmaceutical offers New Pharmaceuticals and Generic Drugs.
Yes, KYORIN Pharmaceutical is publicly traded on TSE under the ticker symbol 4569.
KYORIN Pharmaceutical has made 1 acquisition, including ActivX.
KYORIN Pharmaceutical operates through Kyorin Pharmaceutical Co., Ltd.